Healthy subjects
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.BMI not less than 18.5 kg/m2, under 25.0 kg/m2. 2.FPG less than 126 mg/dL and HbA1c less than 6.5% and 2-hour post-75 g oral glucose tolerance test plasma glucose levels less than 200 mg/dL. 3.Capable of giving informed consent.
Exclusion criteria
Exclusion criteria: 1. Subjects who are treated for diabetes. 2. Subjects who are taking medications for dislipidemia, hypertention, and anemia. 3. Subjects who are taking warfarin. 4. Subjects who are habitually taking medication and/or supplement (including "food for specified health use", and "foods with function claims") that affect glucose metabolism. 5.Subjects who are diagnosed for anemia or have treatment history for anemia. 6. Subjects who are enrollment in another interventional study 7. Subjects who were recognized unsuitable for this study by the Investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incremental area under the curve of plasma glucose (0-120 min) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Plasma glucose level(0-120 min) 2.Plasma insulin level(0-120 min) 3.Organoleptic evaluation(eating quality of test meal) | — |
Countries
Japan
Contacts
University of Tsukuba, Faculty of Medicene Course of clinical research and regional innovation donated by the Japan Agriculture Ibaraki Public